文献速递腹部CTMR

脂肪性肝炎型肝细胞癌:影像表现与临床病理对照

Steatohepatitic hepatocellular carcinoma: imaging findings with clinicopathological correlation.
PubMed 文献 · Clin Radiol · 2020-10-10

本研究评估20例脂肪性肝炎型肝细胞癌(SH-HCC)的临床病理及CT、MRI表现,组织学诊断需具备脂肪变、气球样变、Mallory-Denk小体、间质纤维化、炎症五项中四项。CT上16例(80%)见动脉期强化及延迟廓清,MRI上16例(80%)见明显脂肪沉积伴动脉期强化,提示富血供伴明显脂肪变的病灶应怀疑SH-HCC。

要点

  • SH-HCC在CT上多表现为动脉期强化伴延迟廓清,占16/20(80%)。
  • MRI上80%(16/20)肿瘤见明显脂肪沉积,其中弥漫性10例、局灶性6例,均伴动脉期强化。
  • 富血供病灶伴明显脂肪变时,应提高对SH-HCC的诊断怀疑。

关键影像表现/征象

  • CT上16例(80%)见动脉期强化及延迟廓清。
  • MRI上16例(80%)肿瘤见明显脂肪沉积,其中弥漫性10例、局灶性6例,并伴动脉期强化。
  • 病理上脂肪性肝炎特征弥漫分布12例(60%)、局灶分布8例(40%)。
  • 肿瘤大小与瘤内脂肪变百分比无相关性(r=0.17,p=0.47)。

诊断标准与关键数值

  • SH-HCC组织学诊断标准:肿瘤具备脂肪变(>5%肿瘤细胞)、气球样变、Mallory-Denk小体、间质纤维化、炎症五项中四项。
  • 病理分级:中分化18例(90%),高分化2例(10%)。

临床应用与阅片要点

  • 阅片时对富血供并伴明显脂肪变的肝脏病灶,应结合临床背景考虑SH-HCC的可能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the clinicopathological and computed tomography (CT) and magnetic resonance imaging (MRI) findings of steatohepatitic hepatocellular carcinoma (SH-HCC).

MATERIALS AND METHODS: Clinicopathological and radiological features were evaluated in 20 patients with SH-HCC. The diagnosis of SH-HCC was made histologically if the tumour had four of the following five characteristics: steatosis (>5% tumour cells), ballooning, Mallory-Denk bodies, interstitial fibrosis, and inflammation. All patients underwent dynamic CT and MRI. CT and MRI images were reviewed for morphological features including tumour size, presence, and distribution of fat, and patterns and degree of contrast enhancement.

RESULTS: Obesity, hypertension, and history of heavy alcohol intake were common clinical findings observed in 10 (50%), 13 (65%), and 11 (55%) of the 20 patients, respectively. Steatosis and steatohepatitis were pronounced in the background liver in 12 (60%) and 10 (50%) patients, respectively. SH-HCC was moderately differentiated in 18 patients (90%) and well differentiated in two (10%). Pathologically, steatohepatitic features were diffuse in 12 (60%) of the 20 tumours and focal in eight (40%). Tumour size and the percentage of intratumoural steatosis were not correlated (r=0.17, p=0.47). On CT, 16 (80%) patients showed arterial phase enhancement and delayed washout. On MRI, 16 (80%) of 20 tumours showed prominent fatty deposition (10 diffusely, six focally) with arterial phase enhancement.

CONCLUSIONS: SH-HCC is likely to show prominent fatty deposits with arterial phase enhancement on CT and MRI. A hypervascular lesion with prominent fatty change should raise the diagnostic suspicion of SH-HCC.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Inui S, Kondo H, Tanahashi Y, et al. Steatohepatitic hepatocellular carcinoma: imaging findings with clinicopathological correlation. Clin Radiol. 2020. PMID: 33046228. doi:10.1016/j.crad.2020.09.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。